SciELO - Scientific Electronic Library Online

 
vol.19 issue2-3Obtention and processing of peripheral hematopoietic progenitor cellsThirty years of experience in the use of 32 phosphorus for Polycythemia Vera author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Revista Cubana de Hematología, Inmunología y Hemoterapia

On-line version ISSN 1561-2996

Abstract

CORTINA ROSALES, Lázaro et al. Transfusional therapy in pediatric patients with sickle cell disease. Rev Cubana Hematol Inmunol Hemoter [online]. 2003, vol.19, n.2-3, pp. 0-0. ISSN 1561-2996.

158 children with sickle cell disease, 114 with sickle cell anemia (SCA), 30 with SC haemoglobinopathy (SCH) and 14 with Sb thalasemia (Sb Tal.), were estudied. Of the total, 134 were transfused, 108 of them (94.7 %) with SCA, 14 with SC haemoglobinopathy (SCH) (46.6 %) and 14 with Sb thalasemia (Sb Tal) (85.6 %). They were grouped by age as follows: under 6, betweeen 6 and 12 and from 13 to 18. The transfusion was used more frequently among those under 6 and the main causes were splenic sequestration crisis (SSC), acute thoracic syndrome (ATS) and infections. These causes varied according to age. Exanguinotransfusion was performed in the hepatic crisis, in the vasoocclusive crisis of the central nervous system (VOC-CNS) and in the ATS. The regimen of hypertransfusion was reserved for the VOC-CNS and SSC. The complications detected were: nonhaemolytic febrile reaction, erythrocytary alloimmunization, haemolytic reaction and hepatitis B and C

Keywords : BLOOD TRANSFUSION [adverse effects]; ANEMIA, SICKLE CELL [therapy]; HEMOGLOBIN SC DISEASE [therapy]; INMUNIZATION; CHILD; ADOLESCENT.

        · abstract in Spanish     · text in Spanish

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License